Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
- Status
- COMPLETED
- Phase
- N/A
Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
- Status
- COMPLETED
- Phase
- N/A
The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Cellular Therapy With Cord Blood Cells
- Status
- COMPLETED
- Phase
- PHASE2
Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I/II Study of hLL1 in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3